Diagnostic accuracy for non-alcoholic fatty liver disease (NAFLD) with controlled attenuation parameter (CAP) measured by transient elastography

被引：0
|
作者：
Kikuchi, Masahiro [1 ,2 ]
Umeda, Rumiko [2 ]
Tsuruya, Kota [2 ]
Shiozawa, Hirokazu [2 ]
Kikuchi, Miho [1 ]
Takahashi, Masahiko [1 ]
Horie, Yoshinori [4 ]
Nishizaki, Yasuhiro [3 ]
机构：
[1] Natl Hosp Org, Gastroenterol, Tokyo Med Ctr, Tokyo, Japan
[2] Tokai Univ, Tokyo Hosp, Gastroenterol, Tokyo 151, Japan
[3] Tokai Univ, Tokyo Hosp, Life Care Ctr, Tokyo 151, Japan
[4] Sanno Med Ctr, Int Univ Hlth & Welf, Res Ctr Clin Med, Tokyo, Japan
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2177
引用
收藏
页码：1269A / 1269A
页数：1
相关论文
共 50 条
  • [1] THE EVALUATION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ITS ASSOCIATE FACTORS IN PSORIASIS PATIENTS USING ULTRASONOGRAPHY AND THE CONTROLLED ATTENUATION PARAMETER (CAP) MEASURED WITH TRANSIENT ELASTOGRAPHY
    Sobhonslidsuk, A.
    Pongpit, J.
    Thakkinstian, A.
    Porntharukchareon, S.
    Kaewdoung, P.
    Promson, K.
    Stitchantrakul, W.
    Saengwimol, D.
    Petraksa, S.
    Rajatanavin, N.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S732 - S733
  • [2] Controlled Attenuation Parameter (CAP) for the detection of hepatic steatosis in alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)
    Naveau, Sylvie
    Perlemuter, Gabriel
    Ziol, Marianne
    Carmona, Damien
    Trinchet, Jean Claude
    Prevot, Sophie
    Nohra, Pascal
    Nguefang-Njike, Micheline Nakseu
    Beaugrand, Michel
    [J]. HEPATOLOGY, 2012, 56 : 898A - 898A
  • [3] Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
    Yoneda, M.
    Fujita, K.
    Inamori, M.
    Nakajima, A.
    Yoneda, M.
    Tamano, M.
    Hiraishi, H.
    [J]. GUT, 2007, 56 (09) : 1330 - 1331
  • [4] The impact of controlled attenuation parameter on liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver disease
    Lee, Dong Hyeon
    Kim, Won
    Jung, Yong Jin
    [J]. HEPATOLOGY, 2016, 64 : 539A - 539A
  • [5] Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease
    Handzlik, Gabriela
    Holecki, Michal
    Kozaczka, Joanna
    Kukla, Michal
    Wyskida, Katarzyna
    Kedzierski, Leszek
    Pawlicki, Krzysztof
    Dulawa, Jan
    [J]. PHARMACOLOGICAL REPORTS, 2019, 71 (02) : 183 - 188
  • [6] Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease
    Gabriela Handzlik
    Michał Holecki
    Joanna Kozaczka
    Michał Kukla
    Katarzyna Wyskida
    Leszek Kędzierski
    Krzysztof Pawlicki
    Jan Duława
    [J]. Pharmacological Reports, 2019, 71 : 183 - 188
  • [7] SCREENING FOR NON-ALCOHOLIC FATTY LIVER DISEASE BY TRANSIENT ELASTOGRAPHY WITH CONTROLLED ATTENUATION PARAMETER IN UNSELECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Restellini, Sophie
    Palumbo, Chiara Saroli
    Chao, Che-yung
    Aruljothy, Achuthan
    Sebastiani, Giada
    Bessissow, Talat
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S976 - S976
  • [8] Liver fibrosis by transient elastography in HIV patients with non-alcoholic fatty liver disease (NAFLD)
    Schiavini, M.
    Meraviglia, P.
    Minisci, D.
    Ortu, M.
    Carenzi, L.
    Pocaterra, D.
    Ricci, E.
    Bonfanti, P.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (07) : A59 - A59
  • [9] Comparison of transient elastography and NAFLD fibrosis score in non-alcoholic fatty liver disease
    Wu, Y.
    Weltman, M.
    Eslick, G. D.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 100 - 100
  • [10] Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP)
    Lesmana, Cosmas Rinaldi Adithya
    Kencana, Yoppi
    Rinaldi, Ikhwan
    Kurniawan, Juferdy
    Hasan, Irsan
    Sulaiman, Andri Sanityoso
    Gani, Rino Alvani
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 15 - 22
12345